HLA class I binding of HBZ determines outcome in HTLV-1 infection

PLoS Pathogens

Volumn 6, Issue 9, 2010, Pages

  MacNamara, Aidan ^a   Rowan, Aileen ^a   Hilburn, Silva ^a   Kadolsky, Ulrich ^a   Fujiwara, Hiroshi ^b   Suemori, Koichiro ^b   Yasukawa, Masaki ^b   Taylor, Graham ^a   Bangham, Charles R M ^a   Asquith, Becca ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; TAX PROTEIN;

ALLELE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME SPECIFICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION PREVENTION; NONHUMAN; PATHOGENESIS; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION;

ALLELES; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; EPITOPES; GENE PRODUCTS, TAX; GENES, MHC CLASS I; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PEPTIDE FRAGMENTS; SOFTWARE; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; VIRAL PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 78149290356     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001117     Document Type: Article

References (58)

1. Vine AM, Heaps AG, Kaftantzi L, Mosley A, Asquith B, et al. (2004) The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol 173: 5121-5129.
2. Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, et al. (2005) A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 86: 1515-1523.
3. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, et al. (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 96: 3848-3853.
4. Jacobson S (2002) Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186 Suppl 2: S187-S192.
5. Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S (2000) HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol 102: 208-215.
6. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
7. Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, et al. (1998) Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A 95: 7568-7573.
8. Sundaram R, Sun Y, Walker CM, Lemonnier FA, Jacobson S, et al. (2003) A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine 21: 2767-2781.
9. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, et al. (1991) Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 3: 761-767.
10. Goon PK, Biancardi A, Fast N, Igakura T, Hanon E, et al. (2004) Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis 189: 2294-2298.
11. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, et al. (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 96: 3848-3853.
12. Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CR (1994) Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 68: 2860-2868.
13. Hausmann S, Biddison WE, Smith KJ, Ding YH, Garboczi DN, et al. (1999) Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures. J Immunol 162: 5389-5397.
14. Baalen CA, Guillon C, Baalen Mv M, Verschuren EJ, Boers PH, et al. (2002) Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur J Immunol 32: 2644-2652.
15. Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, et al. (1994) The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 68: 6778-6781.
16. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
17. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, et al. (2007) Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol 81: 4199-4214.
18. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, et al. (2008) Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med 5: e100.
19. Bangham CR (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39: 1700-1712.
20. Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, et al. (2002) The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76: 12813-12822.
21. Kubota R, Hanada K, Furukawa Y, Arimura K, Osame M, et al. (2007) Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs. J Immunol 178: 5966-5972.
22. Pique C, Connan F, Levilain JP, Choppin J, Dokhélar MC (1996) Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. J Virol 70: 4919-4926.
23. Sundaram R, Sun Y, Walker CM, Lemonnier FA, Jacobson S, et al. (2003) A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine 21: 2767-2781.
24. Goon PKC, Biancardi A, Fast N, Igakura T, Hanon E, et al. (2004) Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis 189: 2294-2298.
25. Borghans JAM, Mølgaard A, de Boer RJ, Kesmir C (2007) HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24.
26. Vider-Shalit T, Almani M, Sarid R, Louzoun Y (2009) The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire. Aids 23: 1311-1318.
27. Vider-Shalit T, Sarid R, Maman K, Tsaban L, Levi R, et al. (2009) Viruses selectively mutate their CD8+ T-cell epitopes-a large-scale immunomic analysis. Bioinformatics 25: i39-44.
28. Hoof I, Kesmir C, Lund O, Nielsen M (2008) Humans with chimpanzee-like major histocompatibility complex-specificities control HIV-1 infection. Aids 22: 1299-1303.
29. Schellens IM, Kesmir C, Miedema F, van Baarle D, Borghans JA (2008) An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: the contribution of prediction programs. Aids 22: 33-37.
30. Schmid BV, Kesmir C, de Boer RJ (2009) The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes. BMC Evol Biol 9: 184.
31. Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, et al. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 465: 350-354.
32. Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, et al. (2000) The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165: 7278-7284.
33. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, et al. (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4: 586-593.
34. Vine AM, Witkover AD, Lloyd AL, Jeffery KJM, Siddiqui A, et al. (2002) Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 186: 932-939.
35. Satou Y, Yasunaga J-i, Yoshida M, Matsuoka M (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103: 720-725.
36. Matsuoka M, Green P (2009) The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 6: 71.
37. Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, et al. (2009) HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol 90: 1806-1811.
38. Usui T, Yanagihara K, Tsukasaki K, Murata K, Hasegawa H, et al. (2008) Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 5: 34.
39. Saito M, Matsuzaki T, Satou Y, Yasunaga J-I, Saito K, et al. (2009) In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopa-thy/tropical spastic paraparesis (HAM/TSP). Retrovirology 6: 19.
40. Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, et al. (2003) The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 278: 43620-43627.
41. Li M, Kesic M, Yin H, Yu L, Green PL (2009) Kinetic Analysis of Human T-cell Leukemia Virus Type 1 Gene Expression in Cell Culture and Infected Animals. J Virol.
42. Azuma T, Otsuki T, Kuzushima K, Froelich CJ, Fujita S, et al. (2004) Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Clin Cancer Res 10: 7402-7412.
43. Jiang SB, Ojcius DM, Persechini PM, Young JD (1990) Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins. J Immunol 144: 998-1003.
44. Muller C, Tschopp J (1994) Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J Immunol 153: 2470-2478.
45. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, et al. (2005) An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 35: 2295-2303.
46. Buus S, Lauemøller SL, Worning P, Kesmir C, Frimurer T, et al. (2003) Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 62: 378-384.
47. Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K, et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12: 1007-1017.
48. Macnamara A, Kadolsky U, Bangham CRM, Asquith B (2009) T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules. PLoS Comput Biol 5: e1000327.
49. Heckerman D, Kadie C, Listgarten J (2007) Leveraging information across HLA alleles/supertypes improves epitope prediction. J Comput Biol 14: 736-746.
50. Peters B, Bui H-H, Frankild S, Nielson M, Lundegaard C, et al. (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2: e65.
51. Schmid B, Kesmir C, de Boer RJ (2008) The specificity and polymorphism of the MHC class I prevents the global adaptation of HIV-1 to the monomorphic proteasome and TAP. PLoS ONE 3: e3525.
52. Fortier M-H, Caron E, Hardy M-P, Voisin G, Lemieux S, et al. (2008) The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med 205: 595-610.
53. Borghans JAM, Mølgaard A, de Boer RJ, Kesmir C (2007) HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24.
54. R Development Core Team (2008) R: A Language and Environment for Statistical Computing.
55. Crawley MJ The R Book: John Wiley and Sons, Ltd.
56. Kaslow RA, McNicholl J, Hill AVS (2008) Genetic susceptibility to infectious diseases. New York: Oxford University Press. xvi, 447 p.
57. Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, et al. (2004) Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med 199: 1367-1377.
58. Seiki M, Hattori S, Hirayama Y, Yoshida M (1983) Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A 80: 3618-3622.